Skip to content
Search

Latest Stories

PDA once again reminds pharmacies to maintain zero-tolerance for violence

The Pharmacists Defence Association (PDA) has once again called on contractors to maintain zero tolerance for violence at their respective community pharmacy premises at a time when their staff members are facing tremendous workload due to a global pandemic.

Last year, the association had called for necessary steps by the authorities and all stakeholders to end violence against pharmacists at their workplace.


“The PDA wants to see notices clearly highlighting zero tolerance of violence in every community pharmacy across the UK,” the association said in a latest update to the contractors.

“It is long overdue that all pharmacy employers take their responsibility to end violence seriously and act decisively by enforcing a strict policy of zero tolerance from now on,” it added.

Paul Day, PDA Director said: “Zero-tolerance is absolute and no instance of violence, whether a physical act, threat or abuse, should ever be acceptable in our members’ workplaces. We are calling on each and every pharmacy employer to answer the call to stop violence in pharmacies and they need to act now. To truly make such behaviour unacceptable we need to see the whole sector uniting on this issue and acting as one.”

The Health & Safety Executive (HSE) define violence as “any incident in which a person is abused, threatened or assaulted in circumstances related to their work” and the PDA has a longstanding campaign to end all such instances of violence in pharmacies.

The association is advising that alongside the second wave of the pandemic, there seems to be a further increase of violent behaviour in pharmacies.

The PDA has reminded that all pharmacy employers to publicly stand up against violence by clearly highlighting their zero-tolerance stance. It further suggested the pharmacy teams and contractors to quickly act against any patient or customer who behaves violently at pharmacy premises.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less